Global Cannabis Intellectual Property Symposium 2023 session: IP Litigation and Administrative Proceedings: A Global Overview of Managing Cannabis Conflicts
This panel will address strategies for handling valuation disputes and other post-closing adjustments arising from cannabis M&A, looking at before-the-fact transactional considerations and after-the-fact litigation solutions. We will also consider the availability of state-law restructuring and turnaround remedies given the absence of federal bankruptcy protection for cannabis companies; it’s a hybrid event.
With a new Administration and Congress, changes in personnel at FDA and new safety data being published, is 2021 the year when CBD will come out from under the FDA shadows to be legally marketed in all 50state?
This panel seeks to get to the bottom of the IFR and what it means for the hemp CBD industry currently and in the future. We may also touch on the intersection of USDA and FDA authority to regulate hemp-derived CBD products.
While jurisdictions such as Canada have given us a glimpse into some of the legal issues faced by a country choosing to legalize federally, other models have since emerged. What are these new jurisdictions? What do they have in common? What legal issues are they facing? Join us for a showcase of other countries who have recently “emerged” to join the global adult use, therapeutic, and industrial hemp markets.
Please join Shane Pennington (Counsel, Vicente LLP) as he discusses various aspects of Impact Litigation & the Changing Terrain in the legal cannabis market. This course’s topics will include: the current state of play, historical precedent that got us into the situation we are in today, and what the future may hold.
A comprehensive and dynamic panel designed to equip attorneys with the knowledge and skills necessary to successfully navigate the complex legal landscape surrounding the commercial cannabis industry.